Trial intelligence / Profile preview

Bendamustine and Mitoxantrone in Relapsed/Refractory CLL

NCT00274963Phase 2Completed

Sponsor
German CLL Study Group
Start
Oct 2004
Primary completion
Nov 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of bendamustine in chronic lymphocytic leukemia (CLL), sponsored by German CLL Study Group. Started Oct 2004; status: completed.

02

Drugs

bendamustine
03

Conditions

chronic lymphocytic leukemia (CLL)

Beyond the preview

Go deeper on NCT00274963.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00274963.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call